Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …

Simple Summary According to the American Cancer Society, approximately 53,000 new
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …

Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …

In the past decade, the management of differentiated thyroid cancer (DTC) underwent a
paradigm shift toward the use of risk stratification with the goal of maximizing the benefit and …

Nuclear medicine is an essential tool in the delivery of high-quality medical care, going
beyond simple anatomic imaging to the use of physiologic processes for both imaging and …

Simple Summary Since the 1940s, radioactive iodine has been used for functional imaging
and for treating patients with differentiated thyroid cancer (DTC). During this long-lasting …

Cancer theragnostics is a novel approach that combines diagnostic imaging and
radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …

Abstract Objectives The 2015 American Thyroid Association (ATA) guidelines called for
significantly more selective 131 I therapy in patients with low-risk differentiated thyroid …

This review of radioactive iodide treatment (RAIT) extends from historical origins to its
modern utilization in differentiated thyroid cancer (DTC). The principles embedded in the …

The current therapies against cancer showed limited success. Nanotechnology is a
promising strategy for cancer tracking, diagnosis, and therapy. The hybrid nanotechnology …